Comments
Dr. Reddy’s Laboratories today announced the launch of Sildenafil tablets (20 mg), a bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.
This follows the Hyderabad-based pharma major getting approval from the United States Food & Drug Administration for its abbreviated new drug application.
The Revatio brand, a trademark of Prizer Inc., had US sales of approximately $338.67 million for the most recent 12 months ended September 30, 2012, according to IMS Health.
Dr. Reddy’s Sildenafil tablets in 20 mg are available in 90 count bottle sizes.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.